GlobeNewswire by notified

Reminder of an Investor Conference Webinar

Share

We would like to remind that KN invites shareholders, investors, analysts, and other stakeholders to join its investor conference webinar scheduled on August 25th of 2022 at 9.00 am (EET). The presentation will be held in English.

The webinar will be hosted by KN Chief Executive Officer Darius Šilenskis and Chief Financial Officer Mindaugas Kvekšas who will introduce the performance and unaudited financial results of KN for the six months of 2022.

How to join the webinar?
To join the webinar, please register via following link:
https://nasdaq.zoom.us/webinar/register/WN_-vbo63hsR2q44aSOQ9QeNgYou will be provided with the webinar link and instructions how to join successfully. When joining the webinar for the first time, you will be asked to register on the Zoom platform. The webinar will be recorded and available online for everyone at the company’s website on www.kn.lt/en/and on Nasdaq Baltic youtube.com account.

What is a corporate webinar?
A corporate webinar is a virtual conference, during which company’s representatives provide information about the company and its performance. Webinar allows interactive communication and a possibility to ask questions and get answers directly from the company while being located anywhere.       


Mindaugas Kvekšas, Chief Financial Officer, +370 46 391772

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Auction result of Treasury Bonds - RIKB 27 041519.4.2024 13:30:00 CEST | Press release

Series RIKB 27 0415Settlement Date 04/24/2024Total Amount Allocated (MM) 15,129All Bids Awarded At (Price / Yield) 99.293/8.270Total Number of Bids Received 61Total Amount of All Bids Received (MM) 18,679Total Number of Successful Bids 45Number of Bids Allocated in Full 45Lowest Price / Highest Yield Allocated 99.293/8.270Highest Price / Lowest Yield Allocated 99.750/8.090Lowest Price / Highest Yield Allocated in Full 99.293/8.270Weighted Average of Successful Bids (Price/Yield) 99.471/8.200Best Bid (Price / Yield) 99.750/8.090Worst Bid (Price / Yield) 98.876/8.440Weighted Average of All Bids Received (Price / Yield) 99.422/8.220Percentage Partial Allocation (Approximate) 100.00 %Bid to Cover Ratio 1.23

Netcompany - Final transactions in connection with share buyback programme19.4.2024 13:17:11 CEST | Press release

Company announcement No. 17/2024 19 April 2024 Final transactions in connection with share buyback programme On 25 January 2024, Netcompany Group A/S (“Netcompany”) announced that a share buyback programme of up to DKK 150m and a maximum of 1,300,000 shares had been initiated with the purpose of initiating the redistribution of DKK 2bn to shareholders in line with the midterm 2026 targets. The share buyback programme is executed in accordance with EU Market Abuse Regulation, EU Regulation no. 596/2014 of 16 April 2014 and the provisions of Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the “Safe Harbour Regulation”). The share buyback programme was set to end no later than 1 May 2024. Today, Netcompany announces the final transactions carried out under the current share buyback programme. The following transactions have been executed in the period 16 April 2024 to 18 April 2024: Number of shares Average purchase price, DKK Transaction value, DKK 16-04-2024 20,000 258.0

The deadline for Valoe’s restructuring programme extended until 14.6.2024. Valoe has secured financing for the duration of the proceedings and continues to negotiate longer-term financing.19.4.2024 13:05:00 CEST | Press release

Valoe Corporation Stock Exchange Release 19 April 2024 at 14.05 Finnish time The deadline for Valoe’s restructuring programme extended until 14.6.2024. Valoe has secured financing for the duration of the proceedings and continues to negotiate longer-term financing. Valoe Corporation's ("the Company") restructuring proceedings commenced on 22 January 2024 by the decision of the District Court of North Savo. In accordance with the request of the administrator Pekka Jaatinen, the District Court has extended the deadline for submitting a draft restructuring programme for Valoe until 14 June 2024. The original deadline for submitting a draft restructuring programme was 22 April 2024. Valoe has secured funding for the duration of the restructuring proceedings. The company is actively negotiating long-term financing and ownership arrangements with several parties. The Company's projects with key customers continue as normal. In Mikkeli, 19 April 2024 Valoe Corporation Board of Directors For m

Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 202419.4.2024 13:00:00 CEST | Press release

The Annual General Meeting of Hofseth BioCare ASA for 2024 will be held at the company's premises at Keiser Wilhelms gate 24, 6003 Ålesund, on 10 May 2024 at 13:00 CET. The notice of the Annual General Meeting is attached. For further information, please contact: Jon Olav Ødegård, CEO of Hofseth BioCare ASA Phone: +47 93632966 E-mail: investor@hofsethbiocare.no About Hofseth BioCare ASA: HBC is a Norwegian consumer and pet health ingredient supplier and an incubator for new pharmaceutical drug leads. Research is ongoing to identify the individual elements within its ingredients that modulate inflammation and the immune response with pre-clinical studies ongoing in multiple clinics and university research labs. Lead clinical and pre-clinical candidates are focused on developing an oral treatment for inflammatory disease driven by eosinophils (a type of white blood cell). Clinical trial work with the oil is ongoing to ameliorate lung inflammation in eosinophilic asthma and COPD ("smokers

NetBet Casino slår sig sammen med Stakelogic19.4.2024 12:59:43 CEST | pressemeddelelse

COPENHAGEN, Denmark, April 19, 2024 (GLOBE NEWSWIRE) -- NetBet og Stakelogic har indgået en samarbejdsaftale, som vil bringe Stakelogics spil til NetBets kunder i Danmark. Selvom Stakelogic først blev grundlagt i 2014, har de hurtigt etableret sig som en stor spiller inden for online gaming. Deres omdømme som en nyskaber i branchen er blevet anerkendt, og virksomheden er blevet nomineret til de prestigefyldte kategorier, Industry Innovation of the Year, og Innovation in Casino Entertainment ved SBC Awards 2023. Blandt de mange spil, der er tilgængelige for NetBet Danmarks spillere som et resultat af partnerskabet med Stakelogic, er Book of Cleopatra Super Stake Edition, Volcano Deluxe og Bandits Thunder Link. NetBet Danmarks PR-manager, Claudia Georgevici, udtaler: "Hos NetBet forstår vi vigtigheden af at give vores spillere så mange unikke spil som muligt for at sikre, at de får den bedst mulige spiloplevelse. Stakelogic har et bibliotek af innovative spil, hvilket gør dem til den ide

HiddenA line styled icon from Orion Icon Library.Eye